{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:05:05Z","timestamp":1757700305710},"reference-count":33,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2008,3,12]],"date-time":"2008-03-12T00:00:00Z","timestamp":1205280000000},"content-version":"vor","delay-in-days":2142,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Special Care in Dentistry"],"published-print":{"date-parts":[[2002,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Since 1997, the appetite suppressant drugs fenfluramine\u2010phentermine (fen\u2010phen) and dexfenfluramine have been associated with the development of valvular heart disease. As a result, the drugs have been withdrawn from the market and interim recommendations for evaluation and treatment of exposed patients were issued. However, subsequent studies showed lower prevalence rates for valve abnormalities than were initially reported, and the possibility of such drug\u2010induced lesions resolving has been raised. This article reviews relevant evidence and discusses concerns for the dental practitioner.<\/jats:p>","DOI":"10.1111\/j.1754-4505.2002.tb01172.x","type":"journal-article","created":{"date-parts":[[2008,3,12]],"date-time":"2008-03-12T17:47:34Z","timestamp":1205344054000},"page":"108-114","source":"Crossref","is-referenced-by-count":4,"title":["Diet medications and valvular hearl disease: the current evidence"],"prefix":"10.1111","volume":"22","author":[{"given":"Andrei","family":"Barasch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika M.","family":"Safford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,3,12]]},"reference":[{"key":"e_1_2_1_2_2","unstructured":"LangrethR.Critics claim diet clinics misuse obesity drugs.Wall Street Journal 1997."},{"key":"e_1_2_1_3_2","first-page":"1159","article-title":"Fen\/phen and valvular heart disease: if it sounds too bad to be true, perhaps it isn't","volume":"34","author":"Schiller NB.","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199708283370901"},{"key":"e_1_2_1_5_2","first-page":"1061","article-title":"Cardiac valvulopathy associated with exposure to fenfluramine or dexfenfluramine: U.S. Department of Health and Human Services interim public health recommendations, November 1997","volume":"46","year":"1997","journal-title":"MMWR Morb"},{"key":"e_1_2_1_6_2","first-page":"50","article-title":"Carcinoid heart disease: clinical and echocardiographic and pathologic correlations","volume":"117","author":"Pellikka PA","year":"1992","journal-title":"Ann Intern Med"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-117-1-50"},{"key":"e_1_2_1_8_2","first-page":"2","article-title":"FDA health advisory","volume":"27","author":"Lumpkin MM.","year":"1997","journal-title":"FDA Bulletin"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0894-7317(14)80299-X"},{"key":"e_1_2_1_10_2","first-page":"1519","article-title":"Prevalence and clinical correlates of aortic and mitral regurgitation in a young adult population: the CARDIA study (abstract)","volume":"90","author":"Reid C.","year":"1994","journal-title":"Circulation"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1997.03540460058033"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199809103391101"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199809103391102"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199809103391103"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-129-11_Part_1-199812010-00005"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(87)80254-1"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.75.1.175"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1550-8528.1999.tb00414.x"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(99)00321-6"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.100.21.2161"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.4065\/74.12.1191"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199809103391112"},{"key":"e_1_2_1_23_2","first-page":"1213","article-title":"Dose effect of fenfluramine\u2010phentermine in the production of valvular heart disease. Letter to the editor","volume":"67","author":"Tovar EA","year":"1999","journal-title":"Ann Thorac Surg"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0801020"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.13.1703"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.101.17.2071"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(99)00567-6"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(99)00281-7"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(98)01064-9"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.13.1738"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(00)01008-0"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(89)90344-5"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-131-12-199912210-00008"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.4065\/74.3.290"}],"container-title":["Special Care in Dentistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1754-4505.2002.tb01172.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1754-4505.2002.tb01172.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T15:08:36Z","timestamp":1700320116000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1754-4505.2002.tb01172.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,5]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,5]]}},"alternative-id":["10.1111\/j.1754-4505.2002.tb01172.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1754-4505.2002.tb01172.x","archive":["Portico"],"relation":{},"ISSN":["0275-1879","1754-4505"],"issn-type":[{"value":"0275-1879","type":"print"},{"value":"1754-4505","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,5]]}}}